PART I Overview CVRx is a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular disease. Barostim is the first medical technology approved by the U.S. Food and Drug Administration (the FDA) that uses neuromodulation to improve the symptoms of patients with heart failure (HF). Barostim is an implantable device that delivers electrical pulses to baroreceptors loc...
Q2 FY2026 — expected 2026-08-16
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | CVRX | discussed_in_filing Artificial Intelligence | |
| topic_mention | CVRX | discussed_in_filing Cybersecurity | |
| topic_mention | CVRX | discussed_in_filing Trusted Computing | |
| topic_mention | CVRX | discussed_in_filing Blockchain & Crypto | |
| topic_mention | CVRX | discussed_in_filing Supply Chain | |
| topic_mention | CVRX | discussed_in_filing Regulation | |
| topic_mention | CVRX | discussed_in_filing Healthcare & Bio | |
| topic_mention | CVRX | discussed_in_filing AI Compute | |
| topic_mention | CVRX | discussed_in_filing Platform & Ecosystem | |
| metric | CVRX revenue | reported_in_filing $56.7 million | |
| metric | CVRX revenue | reported_in_filing $51.3 million | |
| topic_mention | CVRX | discussed_in_filing Artificial Intelligence | |
| topic_mention | CVRX | discussed_in_filing Cybersecurity | |
| topic_mention | CVRX | discussed_in_filing Trusted Computing | |
| topic_mention | CVRX | discussed_in_filing Blockchain & Crypto | |
| topic_mention | CVRX | discussed_in_filing Supply Chain | |
| topic_mention | CVRX | discussed_in_filing Regulation | |
| topic_mention | CVRX | discussed_in_filing Healthcare & Bio | |
| topic_mention | CVRX | discussed_in_filing AI Compute | |
| topic_mention | CVRX | discussed_in_filing Platform & Ecosystem |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-13 | 2025-12-31 | 0001104659-26-014708 | EDGAR | 65K words |
| 2025-02-18 | 2024-12-31 | 0001558370-25-001055 | EDGAR | — |
| 2024-02-09 | 2023-12-31 | 0001558370-24-000932 | EDGAR | — |
| 2023-02-10 | 2022-12-31 | 0001558370-23-001114 | EDGAR | — |
| 2022-02-22 | 2021-12-31 | 0001558370-22-001539 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001104659-25-107378 | EDGAR | 19K words |
| 2025-08-05 | 2025-06-30 | 0001558370-25-010186 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0001558370-25-007077 | EDGAR | — |
| 2024-11-01 | 2024-09-30 | 0001558370-24-014078 | EDGAR | — |
| 2024-08-02 | 2024-06-30 | 0001558370-24-010719 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001558370-24-007786 | EDGAR | — |
| 2023-10-31 | 2023-09-30 | 0001558370-23-017121 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0001558370-23-013225 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001558370-23-009381 | EDGAR | — |
| 2022-11-04 | 2022-09-30 | 0001558370-22-016432 | EDGAR | — |
| 2022-08-01 | 2022-06-30 | 0001558370-22-011466 | EDGAR | — |
| 2022-05-02 | 2022-03-31 | 0001558370-22-006644 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-03 | 0001104659-26-022952 | EDGAR | 3K words |
| 2026-02-12 | 0001104659-26-014303 | EDGAR | — |
| 2026-01-12 | 0001104659-26-002743 | EDGAR | — |
| 2026-01-12 | 0001104659-26-002728 | EDGAR | — |
| 2025-11-05 | 0001104659-25-107013 | EDGAR | — |
| 2025-08-04 | 0001104659-25-073638 | EDGAR | — |
| 2025-06-05 | 0001104659-25-056843 | EDGAR | — |
| 2025-05-08 | 0001104659-25-046109 | EDGAR | — |
| 2025-04-07 | 0001104659-25-032626 | EDGAR | — |
| 2025-02-04 | 0001104659-25-009115 | EDGAR | — |
73 total filings indexed. 46 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001235912 |
| Ticker | CVRX |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report